|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00519961 |
|
Date of registration:
|
22/08/2007 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
|
|
Scientific title:
|
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery |
|
Date of first enrolment:
|
February 2007 |
|
Target sample size:
|
1800 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00519961 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Belgium
|
Brazil
|
Former Serbia and Montenegro
|
France
|
Ireland
|
Italy
|
Netherlands
|
Poland
|
|
Serbia
| | | | | | | |
|
Contacts
|
|
Name:
|
Wilma Verhagen-Kamerbeek |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Roche Diagnostics GmbH |
|
|
Name:
|
Roche Diagnostics Center |
|
Address:
|
|
|
Telephone:
|
1-866-805-5919 (U.S. Only) |
|
Email:
|
Dia_StudyInquiries@Roche.com |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adult patients, ≥18 years of age
- Patients with peripheral vascular atherosclerosis, scheduled for vascular surgery
Exclusion Criteria:
- N/A
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Peripheral Vascular Disease
|
|
Intervention(s)
|
|
Device: Elecsys®proBNP
|
|
Primary Outcome(s)
|
|
Collection of 30-day and 1-year postoperative cardiac events
[Time Frame: 30-day and 1-year postoperation]
|
|
Secondary ID(s)
|
|
RD000485
|
|
DECREASE-VI
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|